Explanatory Factors and Predictors of Fatigue in Patients With Sjögren's Disease: A 3-month Longitudinal Study
1 other identifier
observational
100
1 country
1
Brief Summary
This prospective longitudinal study will be conducted in patients diagnosed with Sjögren's disease who are followed at the rheumatology outpatient clinic of Kahramanmaras Sutcu Imam University Medical Faculty Hospital. Demographic and clinical data will be collected from routine clinical assessments and medical records, including laboratory results obtained during standard care. Participants will undergo evaluation of pressure pain threshold using a digital algometer and complete validated questionnaires assessing fatigue, disease activity, patient-reported symptoms, anxiety and depression, pain catastrophizing, sleep quality, and physical activity level. All assessments will be performed at baseline and repeated at follow-up visits approximately 3 months later.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 15, 2026
CompletedStudy Start
First participant enrolled
April 20, 2026
CompletedFirst Posted
Study publicly available on registry
April 22, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 20, 2028
April 27, 2026
April 1, 2026
1.7 years
April 15, 2026
April 22, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Multidimensional Fatigue Inventory-20 (MFI-20)
The MFI-20 is a 20-item self-reported questionnaire assessing fatigue across five dimensions: general fatigue, physical fatigue, mental fatigue, reduced motivation, and reduced activity. Each item is scored on a 5-point Likert scale. Total scores range from 20 to 100, with higher scores indicating greater fatigue.
Baseline and 3-month
Secondary Outcomes (7)
EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI)
Baseline and 3-month
EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI)
Baseline and 3-month
Pressure Pain Threshold (PPT)
Baseline and 3-month
Hospital Anxiety and Depression Scale (HADS)
Baseline and 3-month
Pain Catastrophizing Scale (PCS)
Baseline and 3-month
- +2 more secondary outcomes
Eligibility Criteria
Participants will be recruited from the rheumatology outpatient clinics of Kahramanmaras Sutcu Imam University Medical Faculty Hospital. The study population will consist of adult patients diagnosed with Sjögren's disease who are followed in routine clinical care.
You may qualify if:
- Diagnosis of Sjögren's syndrome
- Age ≥ 18 years
- Willingness to participate and provide written informed consent
You may not qualify if:
- Presence of severe somatic or psychiatric disorders
- Presence of malignancy
- Pregnancy
- Refusal to participate or inability to provide written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kahramanmaras Sutcu Imam University
Kahramanmaraş, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physiotherapist, PhD
Study Record Dates
First Submitted
April 15, 2026
First Posted
April 22, 2026
Study Start
April 20, 2026
Primary Completion (Estimated)
December 30, 2027
Study Completion (Estimated)
April 20, 2028
Last Updated
April 27, 2026
Record last verified: 2026-04